PharmiWeb Today Story
ICON and Advarra have formed a partnership to create a connected site network model designed to make clinical trials easier for research sites to run. The agreement links ICON’s trial technology and services with Advarra’s systems already used by many investigators and study teams worldwide.
The companies said this should reduce administrative burden, improve study startup, and help more sites take part in complex trials. They also plan to support emerging research sites with tools that simplify workflows and widen access to studies. For sponsors, the model is intended to provide better visibility into trial progress and improve planning, site selection, patient recruitment, and overall delivery.
Read More...
Articles
Featured Events
-
Pharmaceutical Manufacturing & Packaging Congress…
28-Jun-2021 - 29-Jun-2021 -
Pharma USA 2022
16-Mar-2022 - 17-Mar-2022 -
Pharmaceutical Manufacturing and Packaging Congres…
20-Jun-2022 - 21-Jun-2022 -
Genomics and Precision Medicine Expo
23-May-2023 - 24-May-2023 -
Working in and Around #MedComms
25-Sep-2023 - 25-Sep-2023 -
Pharmaceutical marketing for non-marketers
26-Sep-2023 - 28-Sep-2023
News
-
Roseman University Launches Roseman Bioventures, a…
24-Mar-2026 -
NBDF’s Pathway to Cures Announces Spark Biomedical…
24-Mar-2026 -
First Trust Global Funds PLC UK Regulatory Announc…
24-Mar-2026 -
Halter Raises $220M in Series E to Accelerate Glob…
24-Mar-2026 -
Federal Judges Order Jason Shurka to Pay Over $54,…
24-Mar-2026 -
Anumana Named to Fast Company’s 2026 Most Innovati…
24-Mar-2026